Genetic testing can identify mutations that may predispose women to certain gynecological conditions. For example, women with BRCA1 or BRCA2 mutations have a higher risk of developing breast and ovarian cancers. Identifying these mutations early can lead to proactive monitoring and preventive strategies, such as or .
